Medical Laboratories & Research

  1. What’s The Drug That Will Finally Fight Obesity?

    Orexigen just pulled back the curtain on interim results for a cardiac study that ...
  2. Should You Invest In Oraganovo Holdings?

    Despite the commercial launch of its bio-printed liver assays last year, Organovo ...
  3. What Could Be The Outcome For Opko Health?

    Investors have pinned high hopes on Opko Health , a development-stage healthcare ...
  4. What Drugs Could Boost Biogen Idec’s Sales?

    Bet against biotechnology giant Biogen Idec and it's likely to sting -- at least ...
  5. What Is Amgen’s New Target?

    Amgen's investors are focusing a lot on its cholesterol-busting drug evolocumab; ...
  6. Multiple Myeloma: A Growing Market For Treatment

    American and European regulators have given Celgene Corporation the OK to begin marketing ...
  1. What’s The Drug That Will Finally Fight Obesity?

    Orexigen just pulled back the curtain on interim results for a cardiac study that ...
  2. Should You Invest In Oraganovo Holdings?

    Despite the commercial launch of its bio-printed liver assays last year, Organovo ...
  3. What Could Be The Outcome For Opko Health?

    Investors have pinned high hopes on Opko Health , a development-stage healthcare ...
  4. What Drugs Could Boost Biogen Idec’s Sales?

    Bet against biotechnology giant Biogen Idec and it's likely to sting -- at least ...
  5. What Is Amgen’s New Target?

    Amgen's investors are focusing a lot on its cholesterol-busting drug evolocumab; ...
  6. Multiple Myeloma: A Growing Market For Treatment

    American and European regulators have given Celgene Corporation the OK to begin marketing ...
  1. Why are oligopolies legal while monopolies are not?

    Learn about oligopolies and monopolies. Explore situations where anti-competitive practices have led to intervention by the ...
Trading Center